Barington Capital Pressures Chemed for Strategic Review, Board Overhaul

Activist investor Barington Capital Group has escalated pressure on Chemed Corp. (NYSE: CHE), demanding the holding company initiate a full strategic review and implement changes to its board of directors. In a letter sent to the board on Tuesday, Barington argued that the true value of Chemed's two distinct businesses is not being realized under the current structure.

Barington's Core Arguments

Barington Chairman and CEO James Mitarotonda, in the letter cited by Bloomberg News, asserted that Chemed has underperformed its peer group and the broader market. The activist firm criticized Chemed's management and board for what it described as a lack of urgency in addressing the company's challenges.

Chemed operates two primary units: Vitas Healthcare, a major hospice provider, and Roto-Rooter, a plumbing and drain-cleaning services firm. Barington questioned whether the multi-business structure has led to under-investment in the Roto-Rooter segment, potentially hampering its growth.

A Slate of Demands

The activist investor outlined several key changes it is pushing for, including:

Ad

• A comprehensive strategic review to unlock shareholder value.
• The development of a plan to improve profitability.
• Significant cost reductions, starting with executive perquisites such as the CEO's personal use of company aircraft and club memberships.
• A complete overhaul of the executive compensation program, following a failed advisory shareholder vote on the matter.
• A board refresh, for which Barington has already recommended a new director candidate.

Context for Investors

This public call to action follows prior private discussions between Barington and Chemed's management, including CEO Kevin McNamara and CFO Michael Witzeman. The activist's campaign introduces a new layer of uncertainty for the Cincinnati-based company, potentially leading to a proxy contest if the board does not engage with Barington's proposals.

A representative for Chemed did not immediately respond to a request for comment on the letter. Investors will be watching for the board's response to Barington's demands and whether the activist pressure will force a re-evaluation of the company's long-term strategy.